NASDAQ:ICCM IceCure Medical (ICCM) Stock Price, News & Analysis $0.61 0.00 (0.00%) (As of 10/4/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends About IceCure Medical Stock (NASDAQ:ICCM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IceCure Medical alerts:Sign Up Key Stats Today's Range$0.61▼$0.6350-Day Range$0.58▼$0.7552-Week Range$0.55▼$1.57Volume410,050 shsAverage Volume512,709 shsMarket Capitalization$27.70 millionP/E RatioN/ADividend YieldN/APrice Target$2.70Consensus RatingBuy Company OverviewIceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.Read More… Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (Ad)Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… IceCure Medical Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks59th Percentile Overall ScoreICCM MarketRank™: IceCure Medical scored higher than 59% of companies evaluated by MarketBeat, and ranked 456th out of 994 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingIceCure Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageIceCure Medical has only been the subject of 1 research reports in the past 90 days.Read more about IceCure Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for IceCure Medical are expected to grow in the coming year, from ($0.27) to ($0.24) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of IceCure Medical is -1.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of IceCure Medical is -1.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioIceCure Medical has a P/B Ratio of 2.25. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about IceCure Medical's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.65% of the float of IceCure Medical has been sold short.Short Interest Ratio / Days to CoverIceCure Medical has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in IceCure Medical has recently decreased by 9.19%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIceCure Medical does not currently pay a dividend.Dividend GrowthIceCure Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.65% of the float of IceCure Medical has been sold short.Short Interest Ratio / Days to CoverIceCure Medical has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in IceCure Medical has recently decreased by 9.19%, indicating that investor sentiment is improving significantly. News and Social Media2.5 / 5News SentimentN/A News SentimentIceCure Medical has a news sentiment score of 1.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for IceCure Medical this week, compared to 1 article on an average week.MarketBeat FollowsOnly 1 people have added IceCure Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, IceCure Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.44% of the stock of IceCure Medical is held by insiders.Percentage Held by InstitutionsOnly 0.62% of the stock of IceCure Medical is held by institutions.Read more about IceCure Medical's insider trading history. Receive ICCM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IceCure Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address ICCM Stock News HeadlinesIceCure Medical Ltd (NASDAQ:ICCM) Short Interest UpdateOctober 1, 2024 | americanbankingnews.comIceCure's ICE3 5-Year Trial Results Published in the Peer Reviewed Annals of Surgical Oncology Journal: ProSense® Cryoablation Without Excision for Early-Stage, Low-Risk Breast Cancer Demonstrates 96.3% Recurrence Free RateSeptember 24, 2024 | prnewswire.comThe panic button has already been pressedIf you missed it, my emergency election broadcast is now available on replay.October 6, 2024 | Porter & Company (Ad)Study Published in the British Journal of Radiology Demonstrates IceCure's ProSense® is a Safe Procedure with 97.7% Technical Success Rate in Treating Tumors of the Lung, Bone, and Soft TissuesSeptember 16, 2024 | prnewswire.comIceCure Medical’s ProSense Positioned for Market Success Following FDA Panel Meeting, Analyst Maintains Buy RatingSeptember 13, 2024 | markets.businessinsider.comFDA AdComm to discuss IceCure's ProSense on Nov. 7September 12, 2024 | msn.comIceCure Announces FDA Advisory Panel Meeting Date for Marketing Authorization of ProSense® in Early-Stage Low Risk Breast Cancer Scheduled for November 7, 2024September 12, 2024 | prnewswire.comIceCure to Meet Institutional Investors at the H.C. Wainwright and Lake Street Capital Markets ConferencesSeptember 4, 2024 | prnewswire.comSee More Headlines ICCM Stock Analysis - Frequently Asked Questions How have ICCM shares performed this year? IceCure Medical's stock was trading at $1.07 at the start of the year. Since then, ICCM shares have decreased by 43.3% and is now trading at $0.6071. View the best growth stocks for 2024 here. How were IceCure Medical's earnings last quarter? IceCure Medical Ltd (NASDAQ:ICCM) released its quarterly earnings results on Tuesday, August, 20th. The company reported ($0.06) EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. The firm earned $1.01 million during the quarter, compared to analysts' expectations of $0.90 million. IceCure Medical had a negative trailing twelve-month return on equity of 111.27% and a negative net margin of 410.22%. How do I buy shares of IceCure Medical? Shares of ICCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Company Calendar Last Earnings8/20/2024Today10/05/2024Next Earnings (Estimated)11/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:ICCM CUSIPN/A CIK1584371 Webwww.icecure-medical.com Phone972-4623-0333Fax972-4623-0222Employees71Year FoundedN/APrice Target and Rating Average Stock Price Target$2.70 High Stock Price Target$2.90 Low Stock Price Target$2.50 Potential Upside/Downside+344.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.33) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,650,000.00 Net Margins-410.22% Pretax Margin-453.76% Return on Equity-111.27% Return on Assets-81.41% Debt Debt-to-Equity Ratio0.03 Current Ratio2.97 Quick Ratio2.54 Sales & Book Value Annual Sales$3.34 million Price / Sales8.30 Cash FlowN/A Price / Cash FlowN/A Book Value$0.27 per share Price / Book2.25Miscellaneous Outstanding Shares45,623,000Free Float44,510,000Market Cap$27.70 million OptionableNot Optionable Beta0.56 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report This page (NASDAQ:ICCM) was last updated on 10/6/2024 by MarketBeat.com Staff From Our Partners⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredGolden Equation: Volatility = OpportunityWhen the market swings wildly, most investors panic… But it doesn't have to be this way. You see, when t...Prosper Trading Academy | SponsoredAI Expert Reveals New PickEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredNext opportunity for crypto millionsAll the Pieces Falling into Place for Crypto… Unlock the Potential of the 2024 Crypto Bull Run!Crypto 101 Media | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IceCure Medical Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share IceCure Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.